Table of Contents

2019 Month : June Volume : 8 Issue : 23 Page : 1816-1819

THE ROLE OF DAILY CO-CARBIDOPA THERAPY IN CHRONIC RESTLESS LEG SYNDROME AND ITS ASSOCIATION WITH AUGMENTATION IN A STUDY IN TERTIARY CARE CENTRE IN SOUTH INDIA.

Mohanakkannan S1, Sowmini P. R2, Sakthi Velayutham3, Malcolm Jeyaraj4, Mugundhan Krishnan5, Arunan S6

1Postgraduate Student, Department of Neurology, Stanley Medical College and Hospital, Chennai, Tamilnadu, India.
2Assistant Professor, Department of Neurology, Stanley Medical College and Hospital, Chennai, Tamilnadu, India.
3Assistant Professor, Department of Neurology, Stanley Medical College and Hospital, Chennai, Tamilnadu, India.
4Assistant Professor, Department of Neurology, Stanley Medical College and Hospital, Chennai, Tamilnadu, India.
5Associate Professor, Department of Neurology, Stanley Medical College and Hospital, Chennai, Tamilnadu, India.
6HOD, Department of Neurology, Stanley Medical College and Hospital, Chennai, Tamilnadu, India.

References :

1

Garcia-Borreguero D, Silber MH, Winkelman JW, et al. Guidelines for the first-line treatment of restless legs syndrome/Willis-Ekbom disease, prevention and treatment of dopaminergic augmentation: a combined task force of the IRLSSG, EURLSSG and the RLS-foundation. Sleep Med 2016;21:1-11.            

CrossRef | Google Scholar | PubMed
2

Winkleman JW, Redline S, Baldwin CM, et al. Polysomnographic and health-related quality of life correlates of restless legs syndrome in the Sleep Heart Health Study. Sleep 2009;32(6):772-8.                              

CrossRef | Google Scholar | PubMed
3

Earley CJ, Silber MH. Restless legs syndrome: understanding its consequences and the need for better treatment. Sleep Medicine 2010;11(9):807-15.          

CrossRef | Google Scholar | PubMed
4

Allen RP, Walters AS, Montplaisir J, et al. Restless legs syndrome prevalence and impact: REST general population study. Arch Intern Med 2005;165(11):1286-92.         

CrossRef | Google Scholar | PubMed
5

Ohayon MM, O’Hara R, Vitiello MV. Epidemiology of restless legs syndrome: a synthesis of the literature. Sleep Medicine Reviews 2012;16(4):283-95.  

CrossRef | Google Scholar | PubMed
6

Allen RP, Earley CJ. Augmentation of the restless legs syndrome with carbidopa/levodopa. Sleep 1996;19(3):205-13.                   

CrossRef | Google Scholar | PubMed
7

Allen RP, Picchietti D, Hening WA, et al. Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology: a report from the Restless Legs Syndrome Diagnosis and Epidemiology Workshop at the National Institutes of Health. Sleep Med 2003;4(2):101-19.                         

CrossRef | Google Scholar | PubMed
8

García-Borreguero D, Allen RP, Kohnen R, et al. Diagnostic standards for dopaminergic augmentation of restless legs syndrome: report from a World Association of Sleep Medicine - International Restless Legs Syndrome Study Group Consensus Conference at the Max Planck Institute. Sleep Med 2007;8(5):520-30.           

CrossRef | Google Scholar | PubMed
9

England JD, Gronseth GS, Franklin G, et al. Distal symmetric polyneuropathy: a definition for clinical research - report of the American Academy of Neurology, the American Association of Electrodiagnostic Medicine and the American Academy of Physical Medicine and Rehabilitation Neurology 2005;64(2):199-207.                          

CrossRef | Google Scholar | PubMed
10

Gupta R, Allan RP, Pundeer A, et al. Hindi translation and validation of Cambridge-Hopkins Diagnostic Questionnaire for RLS (CHRLSq). Ann Indian Acad Neurol 2015;18(3):303-8.          

CrossRef | Google Scholar | PubMed
11

Panda S, Taly AB, Sinha S, et al. Sleep-related disorders among a healthy population in South India. Neurol India 2012;60(1):68-74.            

CrossRef | Google Scholar | PubMed
12

Dauvilliers Y, Winkelmann J. Restless legs syndrome: update on pathogenesis. Current Opinion in Pulmonary Medicine 2013;19(6):594-600.   

CrossRef | Google Scholar | PubMed
13

Garcia-Borreguero D, Williams AM. An update on restless legs syndrome (Willis Ekbom disease): clinical features, pathogenesis and treatment. Curr Opin Neurol 2014;27(4):493-501.        

CrossRef | Google Scholar | PubMed
14

Gemignani F, Brindani F, Vitetta F, et al. Restless legs syndrome in diabetic neuropathy: a frequent manifestation of small fiber neuropathy. J Peripher Nerv Syst 2007;12(1):50-3.                                 

CrossRef | Google Scholar | PubMed
15

Högl B, García-Borreguero D, Kohnen R, et al. Progressive development of augmentation during long-term treatment with levodopa in restless legs syndrome: results of a prospective multi-center study. J Neurol 2010;257(2):230-7.                    

CrossRef | Google Scholar | PubMed